Alera Pharma, Inc. is a newly formed C-Corp wholly owned by Lobe Sciences, Ltd. Mr. Rick Goulburn is appointed as the Chief Executive Officer of Alera Pharma, Inc. Dr. Frederick D. Sancilio has been appointed as Chairman of the Alera Pharma, Inc. whi
VANCOUVER, British Columbia -- Lobe Sciences, Ltd ("Lobe Sciences" or the "Company") (CSE: LOBE), (OTCQB: LOBEF), a biopharmaceutical company focused on developing products to treat diseases with unmet medical needs, today announced that is has formed a wholly owned U.S. subsidiary named Alera Pharma, Inc. (Alera). Alera will be assigned the intellectual property rights focused on the Company’s neurological assets and its new chemical entity Psilocin Mucate. Read More
